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Abstract
Purpose This study was conducted in order to investigate
whether the virulence of the influenza virus infection is
affected by asthma in mice.
Methods Mice with asthma or control mice were infected
with influenza virus. The survival rate, body weight, virus
titer, cytokine profile, and cell infiltration in bronchoalveolar
lavagefluid(BALF)weremeasured. TheNKcellcytotoxicity
was determined by a co-culture system with YAC-1 cells, and
theeffectsofNKcellswereobservedbydepletionofNKcells
using anti-asialoGM1 serum. The virus-specific CD8
+ Tc e l l
killing assay was also performed.
Results When asthmatic or control mice were infected with
non- and sub-lethal doses of influenza virus, the asthmatic
mice were more resistant to the virus than control mice with
regard to the survival rate, the remission of body weight
loss, and the virus burden. Anti-viral cytokines and the NK
cell number were increased in the BALF of asthmatic
mice before the infection. The NK cell cytotoxicity in
the asthmatic mice was significantly enhanced compared
to that in control mice, and the depletion of NK cells in
asthmatic mice was abrogated both the improved
survival rate and the recovery of the body weight loss.
The antigen-specific CD8
+ T cell killing activity in
asthmatic mice was also significantly increased following
the infection compared to that in control mice.
Conclusion NK cell activated by the induction of asthma
and the subsequently activated antigen-specific CD8
+ T
cells could promptly eliminate the viral-infected cells, thus
leading to improvements in the morbidity and mortality of
influenza virus infection.
Keywords Asthmatic mice.influenza virus.NK cell.
antigen-specific CD8
+ T cell
Introduction
At least one strain of influenza virus infects people
worldwide every year. The virus infects the upper and
lower respiratory tract resulting in various symptoms, such
as sudden fever, cough, and headache. The pathogenesis of
the influenza virus infection is influenced by the host’s
genetic, immune, physical, and viral factors [1–3]. Among
these factors, an epidemiological study revealed that asthma
is one of the physical risk factors for a complicated clinical
condition resulting from influenza virus infection [4, 5]. On
the other hand, it has been reported that hospitalized
patients with asthma are less likely to die due to influenza
A virus infection [6]. The reason for these contradictory
findings is unclear. Therefore, the aims of this study were to
investigate whether the pathogenesis of influenza virus
infection is affected by asthma in a mouse model and to
reveal the immunological mechanisms underlying these
effects in vivo.
The prevalence of patients with asthma has dramatically
increased in the last few decades, and asthma now affects
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DOI 10.1007/s10875-011-9619-2more than 300 million people worldwide, especially in
developed countries [7, 8]. Asthma occurs as result of
hyper and chronic inflammatory immune response to a
wide range of antigens in the respiratory tract and is
associated with reversible airflow limitations. Numerous
reports suggest that the development of asthma is related to
the innate immune response, including NK cells, as well as
adaptive immune responses [9]. NK cells in the lungs are
considered to be regulators of Th1 or Th2 cytokine
production, and there is frequently exacerbation of pulmonary
eosinophilia during the early induction stage [10].
The effects of asthma on immune responses against virus
infection have been discussed in rhinovirus infection, which
leads to increased lower airway inflammation [11]. It has
been demonstrated that patients with asthma have an
increased susceptibility to rhinovirus infection, with more
severe lower respiratory tract symptoms and reductions in
lung function than healthy subjects who have similar
infections [12]. Moreover, the immunological effects have
clearly demonstrated that primary bronchial epithelial cells
derived from asthmatic patient increase the susceptibility to
rhinovirus infection, including increased viral replication
and cell lysis, and this is associated with impaired innate
immune responses involved in type I IFN production and
type III IFN-1 production [13, 14].
However, the link between asthma and influenza virus
infection remains unclear. Therefore, we used an ovalbumin
(OVA)-induced asthmatic model mouse to evaluate the
susceptibility of the asthmatic and control mice to influenza
virus infection and examined their immunological
responses against the virus infection.
Materials and Methods
Mice
Female C57BL/6 mice (6 weeks of age) were purchased
from Sankyo Labo Service Co., Inc. (Tokyo, Japan). All
mice were housed under specific pathogen-free conditions
according to the animal protocol guidelines of the
Committee on Animal Care of Tokyo Medical University
(protocol no. S-23023).
Influenza Virus and Treatment Protocols
The influenza virus A/Puerto Rico/8/34 (H1N1) strain was
kindly provided by Dr. Kawaoka of the University of
Tokyo. Mice were intranasally infected with 20 μl of saline
containing the virus under anesthesia. Day 0 was defined as
the day of viral infection throughout the experiments. The
survival rate and body weight were monitored daily until
20 days after the viral infection. The body weight of each
mouse on day 0 before the infection was considered to be
100%. In some experiments, mice were intravenously (i.v.)
injected with 50 μl of anti-asialoGM1 serum (Wako Pure
Chemical Industries, Ltd., Osaka, Japan) to deplete NK
cells or an equivalent amount of normal rabbit serum
(Invitrogen, CA, USA) as a control on days −4 and 0 before
the infection.
Induction of Asthma and Measurement of OVA-Specific
IgE Production and the Histological Examination
of the Trachea and Lungs
Mice were intraperitoneally sensitized with 0.2 ml of
phosphate-buffered saline (PBS) including 10 mg of
ovalbumin (grade V, Sigma, MO, USA) or PBS as a
control every other day for 2 weeks, for a total of seven
injections, and were then allowed to rest for 3 weeks. Mice
were then intranasally challenged with 20 μl of PBS
containing 0.2 mg of OVA or PBS as a control under
anesthesia on days −3, −2, and −1. To estimate the OVA-
specific IgE in the serum and the histology of the
respiratory tract and bronchi on day 0 before the virus
infection, blood samples, trachea tissues, and lungs were
removed from these mice. OVA-specific IgE in the serum
was measured using a mouse OVA-IgE ELISA kit (MD
Bioproducts, MN, USA) according to the manufacturer’s
protocol. Trachea tissues and lungs were fixed with 10%
buffered formalin solution for 72 h, and specimens
embedded in paraffin wax were cut by a microtome. The
sections were stained with hematoxylin–eosin (HE). The
slides were analyzed by a histologist without knowledge of
the identity of the samples.
Analysis of the Changes in Cell Composition
in the Bronchoalveolar Lavage Fluid of Asthmatic Mice
To evaluate the number and types of cells in the
bronchoalveolar lavage fluid (BALF) of asthmatic mice,
the cells in the BALF were obtained from asthmatic or
c o n t r o lm i c eo nd a y0b e f o r e the infection. Their
number and the types of cells were analyzed using an
XT-2000iV automatic blood cell analysis instrument
(Sysmex Corporation, Hyogo, Japan).
Measurement of the Virus Titer
The virus titers in the BALF were estimated by modified
tissue culture infection dose 50 (TCID50) using hemaggluti-
nation as an endpoint. Briefly, confluent Madin–Darby
canine kidney cells in 96-well flat bottom plates were
washed three times with serum-free Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM), and subsequently, DMEM
supplemented with 0.5% bovine serum albumin (BSA),
J Clin Immunol (2012) 32:256–267 257100 μgm l
−1 DEAE dextran, 1 μgm l
−1 TPCK-treated
trypsin, 100 U ml
−1 penicillin, and 100 μgm l
−1 streptomycin
(Sigma) was added in each well followed by incubation with
serially diluted BALF samples at 33°C for 1 h. After gentle
washing, the cells were incubated in 200 μlo fs u p p l e m e n t e d
DMEM in 5% CO2 at 33°C for 3 days. A 150-μla l i q u o to f
the culture supernatants was then removed and mixed with
0.5% chicken red blood cell suspension in 96-well round
bottom plates at 4°C for 3 h. The agglutinated wells were
defined as positive wells. The TCID50 for the virus titer was
calculated by using the Reed and Muench method [15].
Cytokine Assay of the BALF
The cytokine concentrations in the BALF supernatants
were determined using a mouse Interferon Alpha ELISA
Kit (PBL Biomedical Laboratories, NJ, USA) and a mouse
IL-12p40 ELISA development kit, mouse IFN-g ELISA
development kit, mouse IL-6 ELISA development kit,
mouse TNF-α ELISA development kit, mouse IL-4 ELISA
development kit, mouse IL-13 ELISA development kit, or a
mouse IL-22 ELISA development kit (R&D Systems, MN,
USA) according to the manufacturer’si n s t r u c t i o n s ,a s
described previously [16].
Flow Cytometric Analysis
The antibodies used in the flow cytometric (FCM) analysis
were an anti-CD16/CD32 Ab (clone: 2.4 G2) as an FC
blocker, FITC-conjugated anti-CD3ε Ab (clone: 145-2 C11),
PE-conjugated anti-NK1.1 Ab (clone: PK136), and
allophycocyanin-conjugated anti-CD8a Ab (clone: 53–6.7)
(BD Pharmingen, CA, USA). In some experiments, PE-
conjugated H-2D
b Influenza NP tetramer-ASNENMETM
(MBL Co., LTD., Aichi, Japan) was used to detect antigen-
specific cytotoxic T cells. The cells in the BALF or spleen
were stained in PBS with 1% BSA and then fixed with 1%
paraformaldehyde, then the FCM analysis was performed on
a FACSCalibur flow cytometer with the CellQuest Pro
software program.
NK Cell Cytotoxicity Assay
The NK cell cytotoxicity assays were performed using a co-
culture system with YAC-1 cells, which are the target cells
for mouse NK cells. To prepare effector cells, spleen cells
were obtained from asthmatic or control mice on day 0
before the virus infection. After the red cells were lysed,
serially titrated effector cells were co-cultured with 1×10
5
cells ml
−1 of YAC-1 in DMEM supplemented with 10%
FCS, 100 Uml
−1 penicillin, and 100 μgm l
−1 streptomycin
in 96-well round bottom plates at 37°C for 6 h. The level of
lactate dehydrogenase in the culture supernatants, which is
an enzyme released upon cell lysis, was then measured
using the CytoTox 96 non-radioactive cytotoxicity assay kit
(Promega, WI, USA), and the NK cell cytotoxicity was
calculated according to the manufacturer’s procedure.
Cytokine Production in Spleen Cells
Single cell suspensions were prepared from the spleens of
asthmatic or control mice on day 6 after the infection.
These cells were plated at 2.5×10
5 cells/well in 96-well
round bottom plates and stimulated with 1 μg/ml of anti-
CD3 Ab (clone: 145-2 C11) (BD Pharmingen) in DMEM
containing 10% fetal bovine serum, 100 U/ml penicillin,
and 100 μg/ml streptomycin. The supernatants were
collected at 24 h after starting culture and amounts of
IFN-g in the culture supernatants were measured by ELISA
kit (R&D Systems).
In Vivo Killing Assay
An in vivo killing assay for antigen-specific CD8
+ T cells
was performed as described [16, 17]. Briefly, single
splenocytes from naive mice were stained with a PKH26
red fluorescent cell linker kit for general cell membrane
labeling (Sigma). The cells were separated into two equal
populations prior to labeling with 50 nM CFSE (Sigma)
(defined as CFSE
low)o r5 0 0n MC F S E( d e f i n e da s
CFSE
high). The CFSE
low cells were pulsed with 10 μMo f
the nucleoprotein (NP)366–374 of the influenza virus PR8
strain, which includes the ASNENMETM peptide
sequence-restricted MHC class I (H-2D
b)[ 18], for
30 min, while CFSE
high cells were not pulsed. After
washing, the two populations were mixed in equal
proportions, and 1×10
7 cells were injected i.v. into the
non-infected control mice or mice infected with influenza
virus on day 6. At 4 h after the injection, the spleen was
removed from the mice, and single cells were analyzed by
FCM to measure the levels of cytotoxicity. The percent of
the killing activity was calculated by the following formula:
Percent killing activity=100−{[(% CFSE
low in infected
mice / % CFSE
high in infected mice) / (% CFSE
low in
uninfected mice / % CFSE
high in uninfected mice)]×100}.
Statistical Analysis
The statistical analyses were performed using the Statview
ver. 5.0 software program (SAS Institute Inc., NC, USA).
The statistical significance of the findings was calculated
using the Mantel–Cox log rank test for survival experi-
ments. The unpaired t test was used for the in vitro
assays. p values of less than 0.05 were considered to be
statistically significant. All values are presented as the
means ± standard deviation.
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Asthmatic Mice Have Increased OVA-Specific IgE
Production, Histopathological Changes, and a Large
Number of Infiltrated Cells in the BALF
After OVA sensitization, followed by intranasal OVA
challenge in mice, OVA-specific IgE in the serum,
pathological appearances in the trachea and lung, and the
infiltration of cells in the BALF were observed on day 0
before the virus infection. Neither death of the mice nor
acute toxicity, such as a wasted appearance or ruffled fur,
was observed during OVA sensitization and OVA challenge.
OVA-specific IgE in the serum was significantly produced in
mice that were sensitized and challenged with OVA, while no
OVA-specific IgE was found in the serum of control mice
(Fig. 1a). On histological observation, the basement mem-
brane of the trachea specimens of mice sensitized and
challenged with OVA became thickened, and tracheal
epithelial cell hyperplasia was observed in mice administered
with OVA compared to the control mice (Fig. 1b,u p p e r
panels). In addition, as shown in the bottom panels of
Fig. 1b, the infiltration of various types of inflammatory
cells, especially lymphocytes, was observed in the peribron-
chial and perivascular areas in the lungs of mice sensitized
and challenged with OVA, but not in the control mice.
Moreover, excess mucus secreted by bronchial epithelial
cells, which is an important pathophysiological indicator of
allergic asthma, was also observed in mice sensitized and
challenged with OVA. In the analyses of the number or type
of cells present in the BALF using the XT-2000iV, the
numbers of white blood cells (WBC), neutrophils, mono-
cytes, lymphocytes, eosinophils, or basophils in the BALF of
asthmatic mice were higher than those of the control mice
after the induction of asthma before the infection (Table I).
These results suggest that the mice sensitized to and
challenged with OVA would be characterized as having
pathological asthma. These mice were, therefore, used as a
mouse model of asthma in the present study.
Asthmatic Mice Exhibit Lower Susceptibility to Influenza
Virus Infection than the Control Mice
Mice with asthma or control mice were infected with 10,
100, or 1,000 pfu of influenza virus, followed by
monitoring of the survival rate and body weight daily until
day 20. When mice were infected with 10 pfu of the
influenza virus, no deaths were observed in either the
asthmatic or control mice (Fig. 2a). However, the body
weight loss of the asthmatic mice recovered significantly
more compared to that of control mice from day 5 to 13
(Fig. 2b). In addition, when mice were infected with 100
pfu of influenza virus, which is a sub-lethal viral dose in
control mice, the infected control mice started to die around
day 7, and the final survival rate was 50% by the end of the
observation period. On the other hand, the survival rate of
Fig. 1 Asthmatic model mice exhibit increased OVA-specific IgE in
their serum and histopathological changes characterized by allergic
asthma. C57BL/6 mice were intraperitoneally sensitized with OVA or
PBS as a control every other day for 2 weeks, then allowed to rest for
3 weeks. The OVA-sensitized mice or control mice were then
intranasally challenged with OVA or PBS on days −3, −2 and −1,
respectively. Bloods, trachea tissues, and lungs were collected from
the mice on day 0. a The OVA-specific IgE in the serum was
measured by an ELISA assay. b The trachea tissues (upper panels)
and lungs (bottom panels) were stained with HE. Six mice were used
in each group and similar observations were obtained from each
mouse
J Clin Immunol (2012) 32:256–267 259the mice with asthma was 100%, and their body weight loss
was also significantly restored compared to the control mice
from day 3 to 7 (Fig. 2c, d). When the mice, which were
OVA-sensitized without an intranasal challenge with OVA,
were infected with 100 pfu of the virus, both the survival
rate and the body weight loss were comparable to those of
the control mice (data not shown). When the mice were
infected with 1,000 pfu of the influenza virus, no
significant differences in the survival rate and the recovery
of body weight loss were observed between asthmatic
Table I Cellular composition in BALF of asthmatic mice before the infection (×10
5 cells)
WBC Neutrophil Lymphocyte Monocyte Eosinophil Basophil
PBS i.p. + PBS i.n. 1.6 ± 0.3 0.4 ± 0.2 1.0 ± 0.3 0.1 ± 0.1 <10
4 <10
4
OVA i.p. + OVA i.n. 5.6 ± 2.0* 4.5 ± 0.9* 2.5 ± 0.9* 1.0 ± 0.5* 0.2 ± 0.2 0.4 ± 0.2
The mean and standard deviation from six mice/group are shown
*p<0.01 compared to the PBS group
Fig. 2 The survival rate and
recovery of body weight loss
were improved in asthmatic
mice during influenza virus
infection. C57BL/6 mice were
sensitized and challenged with
OVA or PBS. Subsequently, the
mice were infected with 10 (a,
b), 100 (c, d), or 1,000 pfu (e, f)
of influenza virus. The survival
rate (a, c, e) and body weight (b,
d, f) were monitored daily until
day 20. The body weight data of
the dead mouse were excluded
from the analysis from the day
of death onwards. Twelve mice
were evaluated for each group.
Similar results were obtained
from three independent
experiments. *p<0.05 compared
to the body weight of control
mice on the same day. These
results are representative of
three independent experiments
260 J Clin Immunol (2012) 32:256–267model mice and control mice, thus suggesting that mice
with asthma could recover from the pathogenesis of
non- or sub-lethal viral infections and that they were
more resistant to the effects of the virus than the control
mice.
The Virus Titer in the BALF of Asthmatic Mice Is Lower
than That of Control Mice
To determine the virus titer in the BALF during infection,
mice were infected with 100 pfu of the influenza virus, and
the BALF was collected from each mouse on days 2, 4, and
6 after the virus infection. As shown in Fig. 3, the virus
titers in the BALF of mice with asthma were significantly
almost tenfold lower than those in control mice on days 2,
4, and 6 after the virus infection.
Increased Anti-viral Cytokine Production and Decreased
Pro-inflammatory Cytokine Production Are Observed
in Asthmatic Mice Compared to the Control Mice
Because lower virus titers in the BLAF of asthmatic mice
during infection were observed when the mice were
administered a sub-lethal virus dose (Fig. 3), the
concentrations of cytokines, which can directly and/or
indirectly enhance the anti-viral immune responses, such as
IFN-α, IL-12 and IFN-g, and pro-inflammatory cytokines,
such as IL-6 and TNF-α in the BALF were determined by
ELISA assays. Corresponding to the lower virus titer in the
asthmatic mice compared to the control mice, the IL-6
and TNF-α production in the BALF of asthmatic mice
was significantly reduced compared to the control mice
on day 2 or 6, respectively (Fig. 4, bottom). In contrast,
the concentrations of IFN-α,I L - 1 2 ,o rI F N - g in the BALF
of asthmatic mice were significantly higher than those in
control mice on days 2 and 4, days 0, 2, and 4, or day 6,
respectively (Fig. 4, upper panel), thus suggesting that the
increased anti-viral cytokines and decreased inflammatory
cytokines in asthmatic mice were associated with enhanced
viral clearance. On the other hand, the concentration of
Th2 cytokines, such as IL-4, IL13, and IL-22, was
almost below the limit of detection during the virus
infection (data not shown).
NK Cells Migrate from the Spleen to the Lungs of Mice
with OVA-Induced Asthma Before Influenza Virus Infection
It is well known that IFN-α and IL-12, which are produced
on day 0 before the infection, enhance innate immunity,
including NK cell activity, and that IFN-g is produced by
activated NK cells. Therefore, in the present study, the
frequency and number of NK cells in the BALF were
examined. The total numbers of cells significantly increased
in the BALF of asthmatic mice compared to those in the
control mice (Fig. 5a). Moreover, the frequency and
number of NK cells in the BALF of asthmatic mice were
also significantly higher than those in control mice, whose
number of NK cells in the BALF was below 10,000 cells
before the infection (Fig. 5b, c). On the other hand, the
frequency and number of NK cells in the spleens of
asthmatic mice were significantly lower than those of
control mice, although the total number of cells in the
spleens of asthmatic mice was comparable to those in
control mice (Fig. 5d–f), thus suggesting that the increased
number of NK cells in the lungs might have been derived
from the spleen via the circulation following the induction
of asthma.
The NK Cell Cytotoxicity in Asthmatic Mice Is Enhanced,
and the Depletion of NK Cells Abrogates the Resistance
of Mice to Influenza Virus Infection
To determine whether NK cells are responsible for the
improved survival rate and recovery of body weight against
the virus infection, the NK cell cytotoxicity and effects of
NK cell depletion were elucidated. As shown in Fig. 6a, the
NK cell cytotoxicity in the spleens of asthmatic mice was
significantly enhanced with an effector/target ratio of 100:1
compared to the control mice on day 0 before the virus
Fig. 3 The virus titer in asthmatic mice is lower than that in control
mice after influenza virus infection. C57BL/6 mice were sensitized
and challenged with OVA or PBS. The mice were then infected with
100 pfu of the influenza virus. The virus titers in the BALF were
calculated by the TDID50 assay on days 2, 4, and 6 after influenza
virus infection. Six mice were used in each group. *p<0.05 compared
to the virus titer of the control mice. Similar results were obtained
from two independent experiments
J Clin Immunol (2012) 32:256–267 261infection, despite the fact that the frequency and number of
NK cells in the spleens of asthmatic mice were reduced
compared to the control mice (Fig. 5e, f). In addition,
when the asthmatic mice were injected with anti-
asialoGM1 serum to deplete NK cells and the percentages
of NK cells in the BALF and spleens of mice adminis-
tered the anti-asialoGM1 serum were 0.21 ± 0.07% and
0.19 ± 0.05%, respectively, as determined by an FCM
analysis on day 0 before the virus infection, then, the
recovery of body weight and survival of the asthmatic
model mice was abrogated (Fig. 6b, c). The survival rate
and the body weight of the infected asthmatic mice
administered with the anti-asialoGM1 serum were com-
parable to those of the infected non-asthmatic mice
(Fig. 2c, d). This suggests that the migration and
activation of NK cells resulting from induction of asthma
play an important role in the protection against and
recovery from influenza virus infection.
The Enhanced IFN-g Production in Asthmatic Mice
Reinforced the CD8
+ T Cell Activity
Because IFN-g production on day 6 after the infection in
the asthmatic model mice was significantly increased
compared to that in control mice and because spleen cells
stimulated with the anti-CD3 Ab from infected asthmatic
mice significantly increased the IFN-g production com-
pared to that of infected non-asthmatic mice (infected
asthmatic mice 799 ± 225 pg/ml vs. infected control mice
231 ± 109 pg/ml, p<0.01), we examined whether the
antigen-specific CD8
+ T cell killing activity was increased
in the asthmatic mice infected with the influenza virus. The
Fig. 4 Differences were observed in the cytokine production between
asthmatic mice and control mice during influenza virus infection.
C57BL/6 mice were sensitized and challenged with OVA or PBS.
Subsequently, the mice were infected with 100 pfu of the influenza
virus. BALF samples from the mice were collected on day 0 before
viral infection and on days 2, 4, and 6 after influenza virus infection,
and the cytokine concentrations in the BALF supernatants were
measured by ELISA assays. Six mice were used in each group. These
results are representative of two independent experiments. *p<0.05
compared to the cytokine production of control mice. These results are
representative of two independent experiments
262 J Clin Immunol (2012) 32:256–267Fig. 5 There are changes in the frequency and number of NK cells in
the lungs and spleen following the induction of asthma. C57BL/6
mice were sensitized and challenged with OVA or PBS. The BALF
samples or spleens from the mice were collected on day 0 before
influenza virus infection. The total numbers of cells in the BALF (a)
or spleen (d) were counted under a microscope with 0.25% trypan
blue staining. The frequencies of NK cells in the BALF (b) or spleen
(e) were analyzed by FCM. The NK1.1-positive and CD3-negative
lymphocytes were identified to be NK cells. The numbers of NK cells
in the BALF (c) or spleen (f) were calculated by total cell counting.
Twelve mice were evaluated in each group. Similar results were
obtained from two independent experiments
Fig. 6 NK cell cytotoxicity and the effects of NK cell depletion
during influenza virus infection. C57BL/6 mice were sensitized and
challenged with OVA or PBS. The cells in the spleen were considered
to be effector cells and were prepared from asthmatic mice or control
mice on day 0 before the infection. The titrated effector cells and 1×
10
5 cells ml
−1 of YAC-1 cells were co-cultured at various effector/
target ratios, as indicated in the figure. The cytotoxicity percentages
were calculated as described in the “Materials and Methods” (a).
Asthmatic mice were injected i.v. with normal rabbit serum or anti-
asialoGM1 serum on days −4 and 0 before the infection. The survival
rate (b) and body weight (c) were monitored daily until day 20. The
body weight data of the mice that died were excluded from the day of
death onwards. Twelve mice were used in each group. Similar results
were observed from two independent experiments. *p<0.05 compared
to the body weight of control mice on the same day. These results are
representative of two or three independent experiments
J Clin Immunol (2012) 32:256–267 263frequency and number of antigen-specific CD8
+ T cells in
the spleen were not significantly different between the
control and asthmatic mice (Fig. 7a, b). We next examined
the killing activity of antigen-specific CD8
+ T cells via an
in vivo killing assay. As shown in Fig. 7c, the ratio between
the peptide-pulsed CFSE
low cells and unpulsed CFSE
high
cells in the spleens of non-infected asthmatic or control
mice was equal at 4 h after the injection with an equal
mixture of peptide-pulsed and unpulsed cells. On the other
hand, the percentage of peptide-pulsed CFSE
low cells in the
spleen decreased in both infected asthmatic and control
mice. When the percentages of killing activity of infected
asthmatic mice or infected control mice were calculated as
described in the “Materials and Methods” section, the in
vivo killing activity of the T cells in the asthmatic mice
infected with the virus was significantly increased in
comparison to that in control mice infected with the virus
(Fig. 7d).
Discussion
The influenza virus infects the epithelial cells of the upper
and lower respiratory tract by binding to sialic acid on the
cells and is accompanied by various symptoms in the host.
In addition to the virulence of the influenza virus itself,
accumulating retrospective studies suggest that asthma is a
risk factor associated with the severity of the pathogenesis
of influenza virus infection, including infection with the
2009 pandemic influenza A (H1N1) virus [4–6]. On the
other hand, it has been reported that asthma is negatively
associated with death in patients with confirmed infection
with the 2009 pandemic influenza A virus [6]. Therefore,
we examined whether asthma affects the pathogenesis of
influenza virus infection using asthmatic model mice in
vivo. To our knowledge, our findings are the first to
demonstrate that asthmatic mice are more resistant to non-
and sub-lethal doses of influenza virus as a result of a lower
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Fig. 7 The antigen-specific cytotoxicity of CD8
+ T cells following
influenza virus infection. C57BL/6 mice were sensitized and
challenged with OVA or PBS. Subsequently, the mice were
infected with 100 pfu of influenza virus. An FCM analysis and
an in vivo killing activity assay were performed on day 6 after
the infection. Cells in the spleen were incubated with H-2D
b
Influenza NP tetramer followed by staining with both an anti-CD8
Ab and an anti-CD3 Ab and analyzed by FCM. Cells that were CD8-
positive, CD3-positive, and influenza NP tetramer-positive were
identified as antigen-specific CD8
+ T cells (a). The number of
antigen-specific CD8
+ T cells was calculated by total cell counting
(b). Representative FACS data of the in vivo killing assay from non-
infected control or asthmatic mice and infected control or asthmatic
mice are shown (c). The percentages of in vivo killing activity for
asthmatic mice or control mice were calculated as indicated in the
“Materials and Methods” (d). Five mice were used in each group.
Similar results were obtained from two independent experiments
264 J Clin Immunol (2012) 32:256–267viral burden in the lungs than control mice, leading to
improvement of their clinical conditions. The immunological
mechanisms of the prompt viral clearance in asthmatic mice
determined not only increased anti-viral cytokines, such as
IFN-α and IL-12, and activated NK cells in the lungs before
the virus infection, but also may enhance the antigen-specific
CD8
+ T cell activity after the infection.
NK cells are normally present in the lungs, and the
frequency of NK cells in the lungs is the highest compared
to other organs at the steady state [19]. NK cells express a
variety of receptors which enable them to exert a primary
immunosurveillance function and eliminate cancer cells and
infected cells with down-regulated MHC class I [20, 21].
Innate immune responses, including type I IFN and NK cell
responses, are essential following influenza virus infection
for the direct control of viral replication and to limit the
spread of the virus [22]. Moreover, it was recently
confirmed that NKp44 and NKp46 on NK cells in humans
and natural cytotoxicity receptor 1 on NK cells in the
mouse, which is identified as the mouse homolog of human
NKp46, recognize influenza virus hemagglutinins
expressed on influenza virus-infected cells, leading to rapid
recruitment of NK cells and the expansion of the resident
NK cells in the lungs [23–27]. In addition, Ly49H or
Ly49P, which are expressed on NK cells in mice, recognizes
mouse cytomegalovirus (MCMV)-derived proteins m157 and
m04, respectively, and contributes to protecting against
MCMV infection [28–31]. These findings suggest that NK
cell activation plays crucial roles in the primary defense
against the influenza virus or other virus infections [32]. In
fact, our current results provide evidence that depletion of
NK cells of asthmatic mice before influenza virus infection
increases their susceptibility to influenza virus infection,
therefore, increasing their morbidity and mortality
comparable to that of normal mice. However, it is still
unclear whether only NK cells in the lungs of asthmatic
mice are fully responsible for the influenza virus
elimination, because the depletion of NK cells using
anti-asialoGM1 serum depleted not only the local NK
cells in the lungs, but also the total body NK cells,
including those in the spleen, which is a potent resource
of NK cells that migrated to the lungs in this study.
As increased number of NK cells and increased NK cell
activity were observed in patients with asthma, however,
little is known of their role in the development of asthma
[33, 34]. Korsgren et al. clearly demonstrated the contribu-
tion of NK cells in OVA-induced asthma in model mice
[10]. When NK cells were depleted by injection of an
antibody before sensitization and challenge, their mice had
inhibited Th2 responses, such as pulmonary eosinophils,
IL-4 and IL-5 production in the BALF, and decreased
systemic antigen-specific IgE and IL-4-producing cells, but
also had inhibited Th1 responses, including IL-12 production
in the BALF and systemic antigen-specific IgG2a and IFN-g
producing cells, suggesting that NK cells have the potential
to increase in both Th1 and Th2 responses during the
induction of asthma [10]. Our results also demonstrated that
the IFN-α and IL-12 production in the BALF increases in
asthmatic following OVA sensitization and challenge before
the infection. While IFN-α induces anti-viral protein
kinase (PKR), which limits viral replication and induces
apoptosis of the infected cells [35], it is well known that
IFN-α or IL-12 enhances NK cell cytotoxicity and IFN-g
production by NK cells stimulated through NKp46 and
NKG2D, respectively [26, 36]. Thus, activated NK cells
could promptly eliminate the virus-infected cells and
predominantly generate Th1 responses against the virus
infection. Although systemic OVA-specific IgE was signifi-
cantly produced in the asthmatic mice, the Th2 cytokines in
the BALF of the asthmatic mice were minimal in our study.
ThismayhavebeenduetothefrequencyofOVAsensitization
and challenge or the injection with/without alum adjuvant
usedfor the induction ofasthma. Inaddition,wemeasuredthe
cytokines in BALF supernatant, while the supernatants of
lung homogenates were used for the cytokine assays in their
experiments [10].
IFN-g produced by activated NK cells is important in
driving Th1 immune responses, such as antigen-specific
CD8
+ T cell responses [37]. The ability of virus-specific
cytotoxic CD8
+ Tcells to thoroughly prevent the influenza
virus from escaping from the innate immune response has
been demonstrated in CD8
+ T cell-deficient mice [38].
Correspondingly, our findings indicated that enhanced
IFN-g production in the asthmatic mice would lead to the
activation of cytotoxic CD8
+ T cells and was associated
with preventing the mortality caused by a delay in the
clearance of the virus.
Recently, the contamination of commercially available
OVAwith lipopolysaccharide (LPS) has been reported [39].
Watanabe et al. also indicated that the amount of LPS
included in the OVA is sufficient to fully activate
endothelial cells, and the mice treated with LPS-free OVA
as immunogen without alum adjuvant showed more
exacerbation of AHR, lung consolidation, and IgE production
than mice treated with commercially available OVA [39].
Moreover, Eisenbarth et al. have reported that inhalation of a
low level (0.1 μg) of LPS with antigen induces Th2
responses, and a high level (100 μg) of inhaled LPS results
in Th1 responses to inhaled antigen without alum adjuvant
[40]. When commercially available OVA was used to induce
asthma in the present study, a high level of IL-12 production
was observed in the BALF of asthmatic mice. Therefore, the
potential influence of LPS that might have been included in
the OVA on the development of asthma could not be ruled
out, although the concentration of LPS included in the OVA
was not determined.
J Clin Immunol (2012) 32:256–267 265In conclusion, our results suggest that asthmatic model
mice are more resistant to influenza virus infection as a
result of their improved survival rate and more rapid
recovery of body weight than control mice. We have also
demonstrated one of the mechanisms by which bystander
NK cells are activated during the induction of asthma and
contribute to protecting the host against influenza virus
infection. These activated NK cells may not only to
promptly exclude the virus-infected cells by antigen non-
specific bystander effects, but also may increase the
antigen-specific CD8
+ T cell activity, as demonstrated in
the present study. A better understanding of the role of NK
cells in asthmatic mice will provide new insights into viral
infections.
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